World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
32744
World Ranking
14450
National Ranking
7307

Merrill S. Kies publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Merrill S. Kies sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 363 publications — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Merrill S. Kies D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Merrill S. Kies sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Merrill S. Kies is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine, with notable contributions across several subfields including otorhinolaryngology, oncology, pulmonary and respiratory medicine, surgery, and cancer research.

The scientist has extensively worked on topics related to head and neck cancer studies, lung cancer treatments and mutations, head and neck surgical oncology, sinusitis and nasal conditions, cancer genomics and diagnostics, cancer immunotherapy and biomarkers, as well as microtubule and mitosis dynamics.

Frequent co-authors with whom they have collaborated include:

  • Adam S. Garden
  • Adel K. El-Naggar
  • Franco DeMonte
  • Mark S. Chambers
  • Lawrence E. Ginsberg

Throughout their career, Merrill S. Kies has published several papers in respected venues. Recent publications encompass the following:

  • Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study, 2021, npj Precision Oncology
  • A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma, 2020, The Oncologist
  • Induction Chemotherapy with or without Erlotinib in Patients with Head and Neck Squamous Cell Carcinoma Amenable for Surgical Resection, 2022, Clinical Cancer Research
  • Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma, 2024, Clinical Cancer Research
  • Phase II prospective trial of induction chemotherapy for advanced sinonasal squamous cell or poorly differentiated carcinoma, 2023, Journal of Clinical Oncology

The scientist's body of work appears frequently in venues such as Head & Neck, Clinical Cancer Research, npj Precision Oncology, The Oncologist, and Journal of Clinical Oncology. Their contribution to head and neck cancer studies is particularly notable, with multiple publications in this area.

Best Publications

  • Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

    James A. Bonner;Paul M. Harari;Jordi Giralt;Nozar Azarnia

  • A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

    Jean Pierre Pignon;Rodrigo Arriagada;Daniel C. Ihde;David H. Johnson

  • The BATTLE Trial: Personalizing Therapy for Lung Cancer

    Edward S. Kim;Roy S. Herbst;Ignacio Ivan Wistuba;Jiun-Kae Jack Lee

  • Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

    Ezra E.W. Cohen;Lee S. Rosen;Everett E. Vokes;Merrill S. Kies

  • Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical Results

    Hope S. Rugo;Roy S. Herbst;Glenn Liu;John W. Park

  • Head and Neck Cancers, Version 2.2014

    David G. Pfister;Sharon Spencer;David M. Brizel;Barbara Burtness

  • Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck

    Roy S. Herbst;Matthew Arquette;Dong M. Shin;Karel Dicke

  • Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer.

    Mark A. Socinski;Michael J. Schell;Amy Peterman;Kamal Bakri

  • Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial.

    Erminia Massarelli;William William;Faye Johnson;Merrill Kies

  • Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience

    B. Brockstein;D. J. Haraf;Alfred W Rademaker;M. S. Kies

  • Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Protocol 9911

    Corey J. Langer;Jonathan Harris;Eric M. Horwitz;Nicos Nicolaou

  • Head and Neck Cancers

    David G. Pfister;Kie Kian Ang;David M. Brizel;Barbara A. Burtness

  • Randomized Phase III Trial of Induction Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil Followed by Surgery Versus Up-Front Surgery in Locally Advanced Resectable Oral Squamous Cell Carcinoma

    Lai Ping Zhong;Chen Ping Zhang;Guo Xin Ren;Wei Guo

  • Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.

    Mark S. Chambers;Adam S. Garden;Merrill S. Kies;Jack W. Martin

  • Quality of Life and Performance in Advanced Head and Neck Cancer Patients on Concomitant Chemoradiotherapy: A Prospective Examination

    Marcy A. List;Amy Siston;Daniel Haraf;Phil Schumm

  • Weekly Carboplatin and Paclitaxel Followed by Concomitant Paclitaxel, Fluorouracil, and Hydroxyurea Chemoradiotherapy: Curative and Organ-Preserving Therapy for Advanced Head and Neck Cancer

    Everett E. Vokes;Kerstin Stenson;Fred R. Rosen;Merrill S. Kies

  • Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson symptom inventory, head and neck module†

    David Rosenthal;Tito R Mendoza;Mark S Chambers;Joshua A. Asper

  • Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with or without cetuximab

    J. A. Bonner;P. M. Harari;J. Giralt;N. Azarnia

  • Quality of Life in Head and Neck Cancer Patients After Treatment With High-Dose Radiotherapy Alone or in Combination With Cetuximab

    Desmond Curran;Jordi Giralt;Paul M. Harari;K. Kian Ang

  • Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer

    Everett E. Vokes;Merrill S. Kies;Daniel J. Haraf;Kerstin Stenson

Frequent Co-Authors

Adam S. Garden
Adam S. Garden The University of Texas MD Anderson Cancer Center
Bonnie S. Glisson
Bonnie S. Glisson The University of Texas MD Anderson Cancer Center
David I. Rosenthal
David I. Rosenthal The University of Texas MD Anderson Cancer Center
Randal S. Weber
Randal S. Weber The University of Texas MD Anderson Cancer Center
Everett E. Vokes
Everett E. Vokes University of Chicago
Adel K. El-Naggar
Adel K. El-Naggar The University of Texas MD Anderson Cancer Center
George R. Blumenschein
George R. Blumenschein The University of Texas MD Anderson Cancer Center
William H. Morrison
William H. Morrison The University of Texas MD Anderson Cancer Center
K. Kian Ang
K. Kian Ang The University of Texas MD Anderson Cancer Center
Vassiliki A. Papadimitrakopoulou
Vassiliki A. Papadimitrakopoulou The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to a wide range of related fields. Today, many students are choosing online programs to build their skills and enter the healthcare workforce faster. For those interested in healthcare leadership, several healthcare administration degree programs are available online, offering accelerated pathways to management roles in hospitals and clinics.

Nursing remains a rewarding and in-demand profession. If you are a registered nurse looking to advance your career, consider adn to fnp programs that provide flexible online options to become a Family Nurse Practitioner. Nutrition and wellness careers are also on the rise, and enrolling in an accredited nutritionist online degree can prepare you for roles in wellness coaching and clinical nutrition.

Lastly, for those seeking top credentials in healthcare management, accredited cahme accredited online mha programs offer advanced training in leadership and organization within the healthcare sector. Taking these online pathways can help you find your niche and advance your medical or health science career.

Best Scientists Citing Merrill S. Kies

Trending Scientists

Recently Published Articles